114
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Has Progress Been Made in Gastrointestinal Cancer Treatment?

Pages 115-117 | Published online: 08 Jul 2009

  • Albertsson M. Chemoradiotherapy of esophageal cancer. Acta Oncol 2002; 41: 118-23.
  • Glimelius B. Oncology in the Nordic countries--The role of Acta Oncologica? Acta Oncol 2002; 41: 3-5.
  • Stenbeck M, Rose´n M, Holm L-E. Cancer survival in Sweden during three decades 1961-1991. Acta Oncol 1995; 34: 881 -91.
  • Dickman PW, Hakulinen T, Luostarinen T, et al. Survival of cancer patients in Finland 1955-1994. Acta Oncol 1999; 38 (Suppl 12): 1- 103.
  • Sant M, Capocaccia R, Coleman MP, et al. Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer 2001; 37: 1659-67.
  • MacDonald JS, Smalley SR, Benedetti J, et al. Chemoradio-therapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725-30.
  • Neoptolemos JP, Dunn JA, Stocken DD, et al. Adjuvant chemotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 2001; 358: 1576- 85.
  • Janunger K, Hafstro¨m LO, Nygren P, et al. A systematic overview of chemotherapy effects in gastric cancer. Acta Oncol 2001; 40: 309-26.
  • Permert J, Hafstro¨m LO, Nygren P, et al. A systematic overview of chemotherapy effects in pancreatic cancer. Acta Oncol 2001; 40: 361-70.
  • Goggins M, Kern SE, Offerhans JA, et al. Progress in cancer genetics. Lessons from pancreatic cancer. Ann Oncol 1999; 10 (Suppl 4): S4-8.
  • Gatti RA. The inherited basis of human radiosensitivity. Acta Oncol 2001; 40: 702-11.
  • Blanck HM, Tolbert PE, Hoppin JA. Patterns of genetic alterations in pancreatic cancer: a pooled analysis. Environ Mol Mutagen 1999; 33: 111-22.
  • Li D. Molecular epidemiology of pancreatic cancer. Cancer 2001;7:259-65.
  • Withers HR, Peters LJ, Taylor JMG. Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys 1995; 31: 353- 9.
  • Suwinski R, Taylor JMG, Withers HR. Rapid growth of microscopic rectal cancer as a determinant of response to preoperative radiation therapy. Int J Radiat Oncol Biol Phys 1998;42:943-51.
  • Fahlke J, Ridwelski K, Meyer F. Immunhistochemistry of lymph nodes in pancreatic carcinoma. ECCO 11, Lissabon 2001; Abstr 58.
  • Colorectal Cancer Collaborative Group. Adjuvant therapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet 2001; 358: 1291-304.
  • Kapiteijn E, Marijnen CAM, Nagtegaal ID, et al. Preoperative radiotherapy in combination with total mesorectal excision improves local control in resectable rectal cancer. Report from a multicenter randomized trial. For the Dutch Colo Rectal Cancer Group and other cooperative investigators. N Engl J Med 2001; 345: 638 -46.
  • Glimelius B. Pre- or postoperative radiotherapy in rectal cancer --more to learn? Radiother Oncol 2001; 61: 1-5.
  • Glimelius B, Isacsson U. Preoperative radiotherapy for rectal cancer--is 5½ 5 Gy good or a bad schedule? Acta Oncol 2001;40:958-67.
  • Smalley SR, Gunderson L, Tepper J, et al. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys 2002; 52: 283 -93.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.